<DOC>
	<DOCNO>NCT02420990</DOCNO>
	<brief_summary>Attention-Deficit/Hyperactivity Disorder ( ADHD ) exist 20-50 % 3 million adolescent annually enrol outpatient mental health substance use treatment . Adolescents ADHD present deficit attention , self-regulation , social competence significantly impede achievement developmental educational milestone . Currently two evidence-based treatment option age group : academic training stimulant medication . Both option remain vastly underutilized . Academic training available school setting rarely implement clinical care . Similarly , ADHD medication rarely utilized adolescent primary specialty care host reason related stigma , misinformation effect side effect , adolescent autonomy issue . Moreover , widespread fragmentation pharmacological versus behavioral service prevents family make informed treatment selection . The primary objective randomize parametric trial compare effectiveness behavioral versus integrate ( behavioral plus medication decision-making ) intervention adolescent ADHD outpatient behavioral service . The behavioral intervention , Changing Academic Support Home Adolescents ADHD ( CASH-AA ) , contain three component : ADHD psychoeducation , family-based motivational intervention , academic training . The medication decision-making intervention , Medication Integration Protocol ( MIP ) , contain three component : psychoeducation ADHD medication , family decision-making , medication management . The study compare effect two legitimate treatment option adolescent ADHD service utilization , behavioral symptom , quality life . It generate new evidence patient-centered treatment selection aligns family-specific principle treatment goal . This parametric comparative trial randomly assign 140 inner-city adolescent ADHD ( 1 ) CASH-AA Only ( 2 ) CASH-AA + MIP . Treatment occur community behavioral health clinic . All participant receive behavioral intervention ( CASH-AA ) : family psychoeducation ADHD symptom , executive functioning , developmental impact ; family-based motivation ADHD accommodation intervention ; academic training focus home environment support organizational skill . Half participant also receive medication decision-making intervention ( MIP ) : ADHD medication psychoeducation , family decision-making intervention , ( elect start medication ) coordinate medication management . Half sample comorbid substance use problem . Treatment occur three community clinic ; therapist randomly assign study condition . Caregivers adolescent complete assessment baseline , 3 , 6 , 12-month follow-up . Multilevel model compare effectiveness condition key patient service use outcome . Patient-centered analysis explore differential treatment effect base ( ) Medication decision ( yes/no ) ; ( b ) Substance use comorbidity ( yes/no ) ; ( c ) Race/Ethnicity ( Hispanic , African American ) . Quantitative outcome analyse test service use effect , symptom reduction , quality life improvement primary reason seek clinical service . Qualitative interview document family-specific rationale decision medication , compliance behavioral medication intervention , suggestion improve service service integration . Note family assign CASH-AA Only retain option pursue ADHD medication treatment-as-usual procedure respective clinic . Similarly , family assign CASH-AA + MIP require start ADHD medication . Instead , receive informed-choice intervention choose start medication ; study assess impact decision clinical outcome . If proven efficacious , CASH-AA MIP protocol could rapidly disseminate individually integrate protocol routine behavioral healthcare setting . The protocol also readily combine behavioral treatment form multicomponent treatment package adolescents co-occurring behavior problem . In addition , family-based , patient-centered CASH-AA MIP protocol could deliver conjunction family-based treatment individual approach flexibly include caregiver multiple treatment session . This make CASH-AA MIP highly efficient clinical resource address ADHD-related problem outpatient set serf adolescent family .</brief_summary>
	<brief_title>Integrated Treatment Adolescents With ADHD</brief_title>
	<detailed_description />
	<mesh_term>Substance-Related Disorders</mesh_term>
	<criteria>Primary caregiver able participate treatment Adolescent meet DSM5 diagnostic criterion ADHD Adolescents substance user ( 50 % sample ) meet ASAM criterion nonintensive outpatient service Adolescent enrol behavioral treatment Caregiver express desire , adolescent express willingness , participate outpatient treatment Family health benefit meet requirement study treatment site , accept broad range insurance plan include Medicaid . Intellectual Disability AutismSpectrum Disorder Medical/psychiatric illness require hospitalization Current psychotic symptom ; active suicidal ideation Severe substance use problem require immediate relief ( detox residential placement )</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>ADHD</keyword>
	<keyword>Adolescents</keyword>
	<keyword>Substance Use Disorders</keyword>
</DOC>